NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Axolotl Biosciences

Axolotl Biosciences

Private
Victoria, British ColumbiaHealthcare & Life Scienceshttps://www.axolotlbiosciences.com/

Last Round

Grant

Nov 21, 2024

Total Funding Raised

$499,000

Company Overview

Axolotl Biosciences is a biotechnology company that develops and provides bio-inks, 3D tissue models, and consulting services for 3D bioprinting to be used in tissue engineering and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Drug Discovery, 3D Printing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

bioink3D bioprintinghuman tissue modelneural bioinkdrug discoveryinduced pluripotent stem cellshiPSCsregenerative medicinebiotech consumablesanimal testing alternativedrug screeningtissue engineeringbiofabrication3D cell culturedisease modeling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axolotl Biosciences Comparables

Compare Axolotl Biosciences with similar companies based on industry and business-model similarity.

Axolotl Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Axolotl Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 21, 2024
SeedJan 31, 2023
GrantJan 18, 2023
GrantJul 8, 2022
GrantSep 1, 2021
Grant
Jun 17, 2021

Key People

Founding team and executive leadership

Stephanie Willerth

Chief Executive Officer

Executive Team

Axolotl Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 283% MoM, reaching 1K.

  • Nov 21, 2024

    Raised $5K from AM Ventures

Axolotl Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Axolotl Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axolotl Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersVictoria, British Columbia
Employee Range10
Year Founded2020
Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.